TCT
BMY icon

TIAA CREF Trust’s Bristol-Myers Squibb BMY Stock Holding History

TIAA CREF Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$6.53M Sell
120,114
-9,815
-8% -$538K 0.05% 127
2016
Q4 		$7.59M Buy
129,929
+763
+0.6% +$41.7K 0.06% 113
2016
Q3 		$6.96M Buy
129,166
+10,821
+9% +$695K 0.06% 119
2016
Q2 		$8.71M Buy
118,345
+3,244
+3% +$229K 0.08% 98
2016
Q1 		$7.35M Sell
115,101
-7,407
-6% -$467K 0.07% 115
2015
Q4 		$8.43M Buy
122,508
+7,843
+7% +$518K 0.09% 105
2015
Q3 		$6.79M Buy
114,665
+10,624
+10% +$674K 0.08% 110
2015
Q2 		$6.92M Buy
104,041
+1,632
+2% +$108K 0.08% 113
2015
Q1 		$6.61M Buy
102,409
+4,546
+5% +$285K 0.08% 118
2014
Q4 		$5.78M Sell
97,863
-8,614
-8% -$486K 0.07% 120
2014
Q3 		$5.45M Buy
106,477
+2,248
+2% +$112K 0.07% 117
2014
Q2 		$5.06M Sell
104,229
-1,143
-1% -$56.3K 0.07% 117
2014
Q1 		$5.47M Sell
105,372
-7,192
-6% -$383K 0.09% 110
2013
Q4 		$5.98M Buy
112,564
+14,398
+15% +$733K 0.1% 105
2013
Q3 		$4.54M Buy
98,166
+3,243
+3% +$142K 0.09% 111
2013
Q2 		$4.24M Buy
+94,923
New +$4.12M 0.09% 108

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Trust's BMY Position: Q1 2017 in Review

TIAA CREF Trust reduced its Bristol-Myers Squibb (BMY) stake by 7.6% in Q1 2017, selling an estimated $538K and leaving 120,114 shares worth $6.53M. The position accounts for 0.05% of the portfolio, ranked #127.

TIAA CREF Trust first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $8.71M in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • TIAA CREF Trust held 120,114 shares of Bristol-Myers Squibb worth $6.53M as of Q1 2017.
  • TIAA CREF Trust sold 9,815 Bristol-Myers Squibb shares in Q1 2017, an estimated $538K.
  • Bristol-Myers Squibb made up 0.05% of TIAA CREF Trust's portfolio in Q1 2017, its #127 holding.
  • TIAA CREF Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
  • TIAA CREF Trust's Bristol-Myers Squibb position peaked at $8.71M in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.